Jerzy Duszynski
AuthID: R-00F-WZJ
1
TÃTULO: The interplay between p66Shc, reactive oxygen species and cancer cell metabolism Full Text
AUTORES: Magdalena Lebiedzinska-Arciszewska; Monika Oparka; Ignacio Vega-Naredo; Agnieszka Karkucinska-Wieckowska; Paolo Pinton; Jerzy Duszynski; Mariusz R Wieckowski;
PUBLICAÇÃO: 2014, FONTE: Eur J Clin Invest - European Journal of Clinical Investigation, VOLUME: 45
AUTORES: Magdalena Lebiedzinska-Arciszewska; Monika Oparka; Ignacio Vega-Naredo; Agnieszka Karkucinska-Wieckowska; Paolo Pinton; Jerzy Duszynski; Mariusz R Wieckowski;
PUBLICAÇÃO: 2014, FONTE: Eur J Clin Invest - European Journal of Clinical Investigation, VOLUME: 45
INDEXADO EM: 
CrossRef
CrossRef2
TÃTULO: Disrupted ATP synthase activity and mitochondrial hyperpolarisation-dependent oxidative stress is associated with p66Shc phosphorylation in fibroblasts of NARP patients Full Text
AUTORES: Magdalena Lebiedzinska; Agnieszka Karkucinska Wieckowska; Aleksandra Wojtala; Jan M Suski; Gyorgy Szabadkai; Grzegorz Wilczynski; Jakub Wlodarczyk; Catia V Diogo; Paulo J Oliveira; Jan Tauber; Petr Jezek; Maciej Pronicki; Jerzy Duszynski; Paolo Pinton; Mariusz R Wieckowski;
PUBLICAÇÃO: 2013, FONTE: INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, VOLUME: 45, NÚMERO: 1
AUTORES: Magdalena Lebiedzinska; Agnieszka Karkucinska Wieckowska; Aleksandra Wojtala; Jan M Suski; Gyorgy Szabadkai; Grzegorz Wilczynski; Jakub Wlodarczyk; Catia V Diogo; Paulo J Oliveira; Jan Tauber; Petr Jezek; Maciej Pronicki; Jerzy Duszynski; Paolo Pinton; Mariusz R Wieckowski;
PUBLICAÇÃO: 2013, FONTE: INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, VOLUME: 45, NÚMERO: 1
3
TÃTULO: Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
AUTORES: Jan Suski; Magdalena Lebiedzinska; Nuno G Machado; Paulo J Oliveira; Paolo Pinton; Jerzy Duszynski; Mariusz R Wieckowski;
PUBLICAÇÃO: 2011, FONTE: CURRENT DRUG TARGETS, VOLUME: 12, NÚMERO: 6
AUTORES: Jan Suski; Magdalena Lebiedzinska; Nuno G Machado; Paulo J Oliveira; Paolo Pinton; Jerzy Duszynski; Mariusz R Wieckowski;
PUBLICAÇÃO: 2011, FONTE: CURRENT DRUG TARGETS, VOLUME: 12, NÚMERO: 6
